Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents
|
Dec 2015
|
Leuk Res.
|
myelodysplastic syndromes (MDS)
|
Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
|
Mar 2021
|
Bone Marrow Transplantation
|
myelodysplastic syndromes (MDS)
|
Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents.
|
Jul 2015
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Outpatient transfusions for myelodysplastic syndromes
|
Dec 2020
|
Hematology. American Society of Hematology. Education Program
|
myelodysplastic syndromes (MDS)
|
Overview of myelodysplastic syndromes
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
Overview of the Management of Higher-Risk Myelodysplastic Syndromes
|
May 2023
|
The Cancer Journal
|
myelodysplastic syndromes (MDS)
|
p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)
|
Mar 2014
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
Palliative and End-of-Life Care in Myelodysplastic Syndromes
|
Oct 2016
|
Curr Hematol Malig Rep
|
myelodysplastic syndromes (MDS)
|
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study
|
Apr 2021
|
BMJ Supportive & Palliative Care
|
myelodysplastic syndromes (MDS)
|
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease
|
Nov 2020
|
British Journal of Haematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|